Projects per year
Abstract
Hydrophobic tagging (HyT) has emerged as a useful tool within the field of targeted protein degradation for the targeting and removal of a protein of interest (POI) from the cell. Development of new hydrophobic tags with increased efficiency not only allows increased POI degradation but also provides an opportunity to further study the mechanisms of HyT, which are not fully understood. Herein, we describe the development of new theranostic hydrophobic tags that can be used to induce
protein degradation and simultaneously enable drug imaging using stimulated Raman scattering (SRS) microscopy. By coupling our dual-purpose theranostic hydrophobic tags to the PARP inhibiting, anticancer therapeutic olaparib, we explore the degradation efficiency, mode of action and potency that these theranostics confer in ovarian cancer cells. Lead compound 2c effectively degrades intracellular
PARP-1 (DC50 = 0.618 μM, Dmax = 55%) and has more potent antiproliferative activity than the parent compound olaparib (IC50 = 62 nM vs 11.52 μM for olaparib), whilst maintaining on-target PARP inhibitory activity. Using mass spectrometry-based proteomic analysis, we demonstrate activation of the unfolded protein response, ER-stress and cell cycle arrest after incubation with 2c. Using SRS imaging, via the inherent Raman activity of the theranostic alkyne tag, we demonstrate involvement
of the ER and autophagy after treatment with our drug conjugates. These results provide new insight into the mechanisms involved in HyT-induced protein degradation.
protein degradation and simultaneously enable drug imaging using stimulated Raman scattering (SRS) microscopy. By coupling our dual-purpose theranostic hydrophobic tags to the PARP inhibiting, anticancer therapeutic olaparib, we explore the degradation efficiency, mode of action and potency that these theranostics confer in ovarian cancer cells. Lead compound 2c effectively degrades intracellular
PARP-1 (DC50 = 0.618 μM, Dmax = 55%) and has more potent antiproliferative activity than the parent compound olaparib (IC50 = 62 nM vs 11.52 μM for olaparib), whilst maintaining on-target PARP inhibitory activity. Using mass spectrometry-based proteomic analysis, we demonstrate activation of the unfolded protein response, ER-stress and cell cycle arrest after incubation with 2c. Using SRS imaging, via the inherent Raman activity of the theranostic alkyne tag, we demonstrate involvement
of the ER and autophagy after treatment with our drug conjugates. These results provide new insight into the mechanisms involved in HyT-induced protein degradation.
| Original language | English |
|---|---|
| Pages (from-to) | 118413 |
| Journal | European Journal of Medicinal Chemistry |
| Early online date | 28 Nov 2025 |
| DOIs | |
| Publication status | E-pub ahead of print - 28 Nov 2025 |
Keywords / Materials (for Non-textual outputs)
- Hydrophobic tagging
- protein degredation
- autophagy
- olaparib
- SRS imaging
- theranostic
- chemicasl probes
Fingerprint
Dive into the research topics of 'New Mechanistic Insights into Targeted Protein Degradation Using Raman-Active Theranostic Hydrophobic Tags'. Together they form a unique fingerprint.Projects
- 4 Finished
-
Supporting 19F-centered NMR investigations across a range of biological applications
Uhrin, D. (Principal Investigator)
Biotechnology and Biological Sciences Research Council
1/08/23 → 31/07/24
Project: Research
-
Characterising a novel tumour suppressor in Liver cancer
Von Kriegsheim, A. (Principal Investigator)
Melville Trust for the Care and Cure of Cancer
1/09/22 → 30/09/25
Project: Research
-
Characterization of Covalent Warhead Activity for the Development of Targeted covalent inhibitors of Plasmodium Proteasome
Hulme, A. (Principal Investigator) & Punaha Ravindra, M. (Co-investigator)
1/09/21 → 11/02/22
Project: Research